HIT Consultant June 29, 2023
Katrina Rice, Chief Delivery Officer, Biometrics Services at eClinical Solutions

Trial sponsors have made efforts to address underrepresentation and promote Diversity, Equity and Inclusion (DEI) in clinical trials since the Federal and Drug Administration’s (FDA) 2016 guidance, but a new report released by the Government Accountability Office (GAO) still shows a continuous presence of major gaps in patient diversity. It begs the question: how do we ultimately achieve full representation and ensure accountability to uphold the promises we have made for patients?

As the industry transitions from receiving guidance to now having to abide by formal legislation requiring diversity action plans – moving from intention to action – sponsors will have to re-evaluate their processes and how to address this long, overdue industry challenge. If they don’t act now, it...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Clinical Trials, Equity/SDOH, GAO, Govt Agencies, Healthcare System, Survey / Study, Trends
San Francisco hospital receives health equity award from Kaiser, Joint Commission
Inequality in health outcomes in the US: Can we measure this?
Podcast: AAMC Is Working To Thread Healthy Outcomes Through Health Equity
A Year of Bold Progress: IFDHE's Journey Towards Health Equity in 2024
U.S. Has Made Little Progress With Health Equity, Expert Says

Share This Article